Technical Analysis for DEST - Destiny Pharma Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Flat |
| Historical DEST trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Multiple of Ten Bearish | Other | 0.00% | |
| Narrow Range Bar | Range Contraction | -2.33% | |
| NR7 | Range Contraction | -2.33% | |
| Multiple of Ten Bullish | Other | -2.33% | |
| Bearish Engulfing | Bearish | 1.52% | |
| Multiple of Ten Bearish | Other | 1.52% | |
| Wide Bands | Range Expansion | 1.52% | |
| Multiple of Ten Bullish | Other | -3.18% | |
| Wide Bands | Range Expansion | -3.18% | |
| Up 3 Days in a Row | Strength | -3.18% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Get a Trading Sidekick!
Destiny Pharma Plc Description
Destiny Pharma PLC is a United Kingdom-based clinical stage biotechnology company. The Company is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. The exeporfinium chloride (XF) Drug series is the Company’s anti-microbial drug platform and comprises the related XF and drugs described by Destiny Pharma (DPD) drug candidate. Its pipeline for the XF Drug products includes XF-73 Nasal, XF-73 Throat, XF-70 Dermal and XF-70 Lung. XF-73 is a synthetic dicationic porphyrin derivative with antibacterial activity. XF-73 is in the clinical development stage for the prevention of post-surgical staphylococcal infections. XF-73 has completed four Phase I /II A studies in Europe.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Derivative Biotechnology Medicine Clinic Pipe Disease Xf Drugs Prevention Infection Antibiotic Infectious Infectious Disease Medication Bacteria Infections Stage Biotechnology G Series
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 250.0 |
| 52 Week Low | 29.1 |
| Average Volume | 74,822 |
| 200-Day Moving Average | 84.01 |
| 50-Day Moving Average | 136.37 |
| 20-Day Moving Average | 163.98 |
| 10-Day Moving Average | 168.20 |
| Average True Range | 13.09 |
| ADX | 46.08 |
| +DI | 36.85 |
| -DI | 14.47 |
| Chandelier Exit (Long, 3 ATRs ) | 210.73 |
| Chandelier Exit (Short, 3 ATRs ) | 169.57 |
| Upper Bollinger Band | 185.77 |
| Lower Bollinger Band | 142.18 |
| Percent B (%b) | 0.58 |
| BandWidth | 26.58 |
| MACD Line | 10.32 |
| MACD Signal Line | 11.74 |
| MACD Histogram | -1.4182 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 177.89 | ||||
| Resistance 3 (R3) | 178.04 | 174.72 | 176.16 | ||
| Resistance 2 (R2) | 174.72 | 172.07 | 174.64 | 175.58 | |
| Resistance 1 (R1) | 171.11 | 170.44 | 169.45 | 170.96 | 175.00 |
| Pivot Point | 167.79 | 167.79 | 166.96 | 167.72 | 167.79 |
| Support 1 (S1) | 164.18 | 165.15 | 162.52 | 164.04 | 160.00 |
| Support 2 (S2) | 160.86 | 163.51 | 160.79 | 159.42 | |
| Support 3 (S3) | 157.26 | 160.86 | 158.84 | ||
| Support 4 (S4) | 157.11 |
